The move brings down the cost to less than forty-dollars, every three weeks.
It's one of five new drugs added to the Pharmaceutical Benefits Scheme.

A box of Keyruda, a medication used to treat Hodgkin?s lymphoma. Source: AAP
The move brings down the cost to less than forty-dollars, every three weeks.
It's one of five new drugs added to the Pharmaceutical Benefits Scheme.